High Mobility Group Box1 (HMGB1) released from cancer cells induces the expression of pro-inflammatory cytokines in peritoneal fibroblasts

Pathology International

Volumn 64, Issue 6, 2014, Pages 267-275

  Abe, Anna ^a,b   Kuwata, Takeshi ^b   Yamauchi, Chisako ^b   Higuchi, Youichi ^a,b   Ochiai, Atsushi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Cancer; HMGB1; Inflammation; Peritoneal fibroblasts; TLR 2; TLR 4

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; MESSENGER RNA; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; CULTURE MEDIUM; TOLL LIKE RECEPTOR;

ARTICLE; CACO 2 CELL LINE; CANCER CELL; CANCER GROWTH; FIBROBLAST; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA SEQUENCE; STOMACH CANCER; STOMACH CARCINOGENESIS; WESTERN BLOTTING; CULTURE MEDIUM; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; CYTOKINES; FIBROBLASTS; HMGB1 PROTEIN; HUMANS; INFLAMMATION; NF-KAPPA B; STOMACH NEOPLASMS; TOLL-LIKE RECEPTORS;

EID: 84903180070     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12167     Document Type: Article

References (31)

1. Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P. HMGB1: Guiding immunity from within. Trends Immunol 2005; 26: 381-387.
2. Tang D, Kang R, Zeh HJ, III, Lotze MT. High-mobility group box 1 and cancer. Biochim Biophys Acta 2010; 1799: 131-140.
3. Ulloa L, Messmer D. High-mobility group box 1 (HMGB1) protein: Friend and foe. Cytokine Growth Factor Rev 2006; 17: 189-201.
4. Wang H, Yang H, Tracey KJ. Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 2004; 255: 320-331.
5. Sun N-K, Chao CCK. The cytokine activity of HMGB1-extracellular escape of the nuclear protein. Chang Gung Med J 2005; 28: 673-682.
6. Kuniyasu H, Oue N, Wakikawa A etal. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J Pathol 2002; 196: 163-170.
7. Zhang J, Zhu J-S, Zhou Z, Chen W-X, Chen N-W. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo. Oncol Rep 2012; 27: 1511-1519.
8. Maeda S, Hikiba Y, Shibata W etal. Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer. Biochem Biophys Res Commun 2007; 360: 394-400.
9. Tang DL, Kang R, Zeh HJ, Lotze MT. High-mobility group box 1 and cancer. Biochim Biophys Acta 2010; 1799: 131-140.
10. Mutoh N, Tani-Ishii N, Tsukinoki K, Chieda K, Watanabe K. Expression of toll-like receptor 2 and 4 in dental pulp. J Endod 2007; 33: 1183-1186.
11. Sarah SM, Tamilselvan S, Kamatchiammal S, Suresh R. Expression of Toll-like receptors 2 and 4 in gingivitis and chronic periodontitis. Indian J Dent Res 2006; 17: 114-116.
12. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in Inflammation and Cancer. Annu Rev Immunol 2010; 28: 367-388.
13. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
14. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401.
15. Singer AJ, Clark RAF. Mechanisms of disease-Cutaneous wound healing. N Engl J Med 1999; 341: 738-746.
16. Rogler G, Gelbmann CM, Vogl D etal. Differential activation of cytokine secretion in primary human colonic fibroblast/myofibroblast cultures. Scand J Gastroenterol 2001; 36: 389-398.
17. Lin M-T, Lin B-R, Chang C-C etal. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway. Int J Cancer 2007; 120: 2600-2608.
18. Kim D-K, Oh SY, Kwon H-C etal. Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer 2009; 9: 155.
19. Park JS, Svetkauskaite D, He QB etal. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279: 7370-7377.
20. Yanagihara K, Tanaka H, Takigahira M etal. Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice. Cancer Sci 2004; 95: 575-582.
21. Witowski J, Jorres A. Peritoneal cell culture: Fibroblasts. Perit Dial Int 2006; 26: 292-299.
22. Hoshino A, Ishii G, Ito T etal. Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: Podoplanin in fibroblast functions for tumor progression. Cancer Res 2011; 71: 4769-4779.
23. Hippo Y, Yashiro M, Ishii M etal. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 2001; 61: 889-895.
24. Semba S, Itoh N, Ito M, Harada M, Yamakawa M. The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenyl-chromone (LY294002), a specific inhibitor of phosphatidylinositol 3 '-kinase, in human colon cancer cells. Clin Cancer Res 2002; 8: 1957-1963.
25. Kay J, Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology 2004; 43: 2-9.
26. LeBouder E, Rey-Nores JE, Rushmere NK etal. Soluble forms of toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J Immunol 2003; 171: 6680-6689.
27. Andersson U, Wang HC, Palmblad K etal. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000; 192: 565-570.
28. Yang H, Ochani M, Li JH etal. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 2004; 101: 296-301.
29. Li JH, Wang HC, Mason JM etal. Recombinant HMGB1 with cytokine-stimulating activity. J Immunol Methods 2004; 289: 211-223.
30. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute-inflammation. J Leukoc Biol 1994; 56: 559-564.
31. Gregory AD, Houghton AM. Tumor-associated neutrophils: New targets for cancer therapy. Cancer Res 2011; 71: 2411-2416.